Single European Currency and Monetary Union: Macroeconomic Implications for Pharmaceutical Spending

Author： Kanavos P.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.13, Iss.1 Part 2, 1998-01, pp. : 9-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Overview of the European Union's New Medicines Legislation: Implications for the Pharmaceutical Industry

By Jackman Margaret   Woods Kent  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 4, 2006-01 ,pp. : 251-261

Adis International

Access to resources Recommend Favorite

Continuing Medical Education and Professional Development in the European Union: Evolution and Implications for Pharmaceutical Medicine

By Silva Honorio  

Pharmaceutical Medicine, Vol. 26, Iss. 4, 2012-08 ,pp. : 223-233

Adis International

Access to resources Recommend Favorite

Pharmaceutical biotechnology products approved within the European Union

By Walsh G.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 55, Iss. 1, 2003-01 ,pp. : 3-10

Elsevier

Access to resources Recommend Favorite

EFPIA workshop: the 2001 review of European Union pharmaceutical legislation

By Donna E.   Elena M.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 3, 2001-06 ,pp. : 145-149

Adis International

Access to resources Recommend Favorite

The Pharmaceutical Group of the European Union (PGEU) has published guidelines

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 326, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite